| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| daratumumab | adp-ribosyl cyclase 1 | biotech | NA | drugbank , DGIDB | Amyloidosis[MeSHID:D000686] Multiple Myeloma[MeSHID:D009101] Light[MeSHID:D008027] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
127.3 | approved | antibody |
| daratumumab | cyclic adp-ribose hydrolase 1 | NA | Successful target | TTD , DGIDB | Amyloidosis[MeSHID:D000686] Multiple Myeloma[MeSHID:D009101] Light[MeSHID:D008027] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
127.3 | approved | inhibitor |
| daratumumab | cyclic adp-ribose hydrolase 1 | NA | Successful target | TTD , DGIDB | Amyloidosis[MeSHID:D000686] Multiple Myeloma[MeSHID:D009101] Light[MeSHID:D008027] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
127.3 | approved | antibody |
| daratumumab | adp-ribosyl cyclase 1 | biotech | NA | drugbank , DGIDB | Amyloidosis[MeSHID:D000686] Multiple Myeloma[MeSHID:D009101] Light[MeSHID:D008027] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
127.3 | approved | antibody,inhibitor |
| daratumumab | cyclic adp-ribose hydrolase 1 | NA | Successful target | TTD , DGIDB | Amyloidosis[MeSHID:D000686] Multiple Myeloma[MeSHID:D009101] Light[MeSHID:D008027] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
127.3 | approved | unknown |
| click here to return to the previous page | ||||||||